If you wish to reach out to him to chat, or to offer any ideas, please follow him on Twitter at @Grimviper666 The Phantom ...

BitSummit 2026 is fast approaching, so be sure to jump into these charming indie gems you might have missed.

A condition that leaves people with two sets of DNA may be on the rise – and it’s posing thorny questions for families and ...

The FDA has approved vepdegestrant (Veppanu), the first proteolysis targeting chimera (PROTAC) therapy, for ESR1‑mutated advanced breast cancer, while UK regulators are preparing to review uniQure’s ...

A month ahead of its June 5 PDUFA date, Arvinas Inc.’s vepdegestrant gained U.S. FDA approval for use in a specific type of advanced or metastatic breast cancer, becoming the first proteolysis ...

Known as Veppanu, the drug is the first of its kind to get to market. But Arvinas and partner Pfizer are still searching for ...

The X-Men have the hardest mission in comics and readers have been introduced to some dark versions of Marvel's Merry Mutants ...

Approval received in advance of FDA-assigned PDUFA date of June 5, 2026; Arvinas and Pfizer remain on track to announce selection of a third party – – VEPPANU offers a new therapeutic option in ...

The FDA approved oral vepdegestrant (Veppanu) for adults with advanced or metastatic estrogen receptor ...

Simon Kim is known for opening buzzy, unapologetically over-the-top restaurants. It started with the 2017 launch of Cote, a ...

Arvinas said Friday the FDA approved the drug, known generically as vepdegestrant, to treat adults with certain forms of advanced metastatic breast cancer whose disease worsened following at least one ...

A roundup of recent products in the GNSS and inertial positioning industry from the March-April 2026 issue of GPS ...